1. Home
  2. MRSN vs WIMI Comparison

MRSN vs WIMI Comparison

Compare MRSN & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • WIMI
  • Stock Information
  • Founded
  • MRSN 2001
  • WIMI 2015
  • Country
  • MRSN United States
  • WIMI China
  • Employees
  • MRSN N/A
  • WIMI N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • MRSN Health Care
  • WIMI Technology
  • Exchange
  • MRSN Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • MRSN 37.0M
  • WIMI 38.3M
  • IPO Year
  • MRSN 2017
  • WIMI 2020
  • Fundamental
  • Price
  • MRSN $7.66
  • WIMI $4.24
  • Analyst Decision
  • MRSN Strong Buy
  • WIMI
  • Analyst Count
  • MRSN 3
  • WIMI 0
  • Target Price
  • MRSN $33.00
  • WIMI N/A
  • AVG Volume (30 Days)
  • MRSN 90.2K
  • WIMI 190.8K
  • Earning Date
  • MRSN 08-13-2025
  • WIMI 01-01-0001
  • Dividend Yield
  • MRSN N/A
  • WIMI N/A
  • EPS Growth
  • MRSN N/A
  • WIMI N/A
  • EPS
  • MRSN N/A
  • WIMI 1.00
  • Revenue
  • MRSN $34,769,000.00
  • WIMI $74,245,408.00
  • Revenue This Year
  • MRSN N/A
  • WIMI N/A
  • Revenue Next Year
  • MRSN N/A
  • WIMI N/A
  • P/E Ratio
  • MRSN N/A
  • WIMI $3.97
  • Revenue Growth
  • MRSN 16.14
  • WIMI N/A
  • 52 Week Low
  • MRSN $5.21
  • WIMI $2.24
  • 52 Week High
  • MRSN $70.75
  • WIMI $29.20
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 54.20
  • WIMI 61.37
  • Support Level
  • MRSN $6.63
  • WIMI $3.58
  • Resistance Level
  • MRSN $7.25
  • WIMI $4.07
  • Average True Range (ATR)
  • MRSN 0.52
  • WIMI 0.24
  • MACD
  • MRSN 0.02
  • WIMI 0.01
  • Stochastic Oscillator
  • MRSN 65.86
  • WIMI 89.47

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: